BRISTOL MYERS SQUIBB CO (BMY) vs PFIZER INC (PFE)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | BMY | PFE |
|---|---|---|
| Sector | Health Care | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $48.19B | $62.58B |
| Revenue growth (YoY) | ▼ 0.2% | ▼ 1.6% |
| Net income | $7.05B | $7.77B |
| Gross margin | 71.1% | 74.3% |
| Diluted EPS | $3.46 | $1.36 |
| Insider net (6 mo) | +46.8K sh • 2 sells • 0 buys | +109.6K sh • 2 sells • 3 buys |
| Institutional owners | 47 | 43 |
| Institutional value held | $63.76B | $61.91B |
| Next earnings (est.) | Oct 29, 2026 | Nov 3, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About BRISTOL MYERS SQUIBB CO (BMY)
Bristol-Myers Squibb Company, incorporated in Delaware in 1933 as successor to a New York business dating to 1887 and renamed following a 1989 merger, is a biopharmaceutical company operating in a single segment focused on discovering, developing… Read more →
About PFIZER INC (PFE)
Pfizer Inc. is a research-based, global biopharmaceutical company incorporated in Delaware in 1942 that applies science and global resources to discover, develop, manufacture, market, sell and distribute biopharmaceutical products worldwide, operating across… Read more →
Source: SEC EDGAR.